Published in Br J Haematol on February 01, 1976
Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51
Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science (1988) 2.31
Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol (1993) 2.28
A survey of hepatitis B surface antigen-positive blood donors: degree of understanding and action taken after notification. Transfusion (1992) 1.53
The liabilities of iron deficiency. Blood (1986) 1.49
Accelerated oxidative catabolism of ascorbic acid in siderotic Bantu. Am J Clin Nutr (1967) 1.29
Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol (1995) 1.26
The effect of tea on iron absorption. Gut (1975) 1.23
Effects of iron overload on ascorbic acid metabolism. Br Med J (1968) 1.22
Interaction of vitamin C and iron. Ann N Y Acad Sci (1980) 1.18
Estimates of iron sufficiency in the US population. Blood (1986) 1.15
Soy protein, phytate, and iron absorption in humans. Am J Clin Nutr (1992) 1.13
Osteoporosis, scurvy, and siderosis in Johannesburg bantu. Br Med J (1966) 1.12
Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. N Engl J Med (1985) 1.09
Some factors affecting the release of iron from reticuloendothelial cells. Br J Haematol (1971) 1.09
Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr (1992) 1.07
Arteriovenous potassium changes and ventricular arrhythmias after coronary artery occlusion. Cardiovasc Res (1970) 1.05
Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and related conditions in premature infants. Am J Obstet Gynecol (1995) 1.05
Assessment of the role of nonheme-iron availability in iron balance. Am J Clin Nutr (1991) 1.05
A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group. Thromb Haemost (1997) 1.04
The effect of ascorbic acid deficiency on desferrioxamine-induced urinary iron excretion. Br J Haematol (1969) 1.02
Duodenal iron proteins in idiopathic hemochromatosis. J Clin Invest (1989) 1.01
Iron absorption from legumes in humans. Am J Clin Nutr (1984) 0.98
The effect of plasma human immunodeficiency virus RNA and CD4(+) T lymphocytes on growth measurements of hemophilic boys and adolescents. Pediatrics (2001) 0.96
F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Haemophilia (2012) 0.94
Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events. Haemophilia (2002) 0.94
Factor VIII and factor VIII related antigen in normal South African Blacks and a Black carrier group. Thromb Res (1976) 0.93
The mechanism of the inhibition of iron absorption by tea. S Afr J Med Sci (1975) 0.93
The effects of ascorbic acid supplementation on the absorption of iron in maize, wheat and soya. Br J Haematol (1973) 0.93
Inhibition of food iron absorption by coffee. Am J Clin Nutr (1983) 0.93
Serum ferritin as an index of iron nutrition in rural and urban South African children. Br J Nutr (1978) 0.92
Violence in the lives of pregnant teenage women: associations with multiple substance use. Am J Drug Alcohol Abuse (1999) 0.91
Role of gastric acid in food iron absorption. Gastroenterology (1981) 0.90
Tumor-associated antigens in breast carcinomas. Prognostic significance. Cancer (1987) 0.90
Dialysis and renal transplant in a hemophiliac. Thromb Haemost (1981) 0.90
Potency and mass of factor VIII in FVIII products. Haemophilia (2008) 0.89
Procedures for the inactivation of viruses in clotting factor concentrates. Am J Hematol (1986) 0.89
Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study. J Pediatr (1994) 0.89
Iron absorption in humans: bovine serum albumin compared with beef muscle and egg white. Am J Clin Nutr (1988) 0.88
Handling of highly infectious material in a clinical pathology laboratory and in a viral diagnostic unit. S Afr Med J (1978) 0.88
Double contrast arthrography of the knee. A comparison to clinical diagnosis and arthroscopic findings. Orthopedics (1988) 0.88
Increased coronary venous inorganic phosphate concentrations during experimental myocardial ischemia. Am J Cardiol (1972) 0.88
Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. The Hemophilia Growth and Development Study. Haemophilia (1999) 0.88
Quantitative bacteriology in wound care. Am Surg (1979) 0.87
Heparin, brain thromboplastin and the insensitivity of the prothrombin time to heparin activity. Thromb Res (1978) 0.87
Storage iron in "muscle". J Clin Pathol (1968) 0.87
Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study. Pediatrics (2001) 0.86
LAV/HTLV III presence in peripheral blood lymphocytes of seropositive young hemophiliacs. Blood (1985) 0.85
Extramedullary plasmacytoma of the breast. J Pathol (1975) 0.85
Iron absorption from a cereal-based meal containing cane sugar fortified with ascorbic acid. Br J Nutr (1977) 0.85
The pH dependence of cytochrome a conformation in cytochrome c oxidase. J Biol Chem (1991) 0.85
The effect of siderosis and ascorbic acid depletion on bone metabolism, with special reference to osteoporosis in the Bantu. Br J Nutr (1971) 0.85
The inhibitory effect of soy products on nonheme iron absorption in man. Am J Clin Nutr (1981) 0.85
[Preliminary evaluation of composite materials for the repair of incisional hernias]. Ann Chir (1995) 0.84
Iron absorption from rice meals cooked with fortified salt containing ferrous sulphate and ascorbic acid. Br J Nutr (1974) 0.84
Quality of commercially available controls in laser immunonephelometry. Ann Clin Biochem (1980) 0.84
Alpha-chain disease in a non-Mediterranean climate. A case report. S Afr Med J (1975) 0.84
Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial. J Vasc Surg (1999) 0.84
Iron status of elderly Americans. Am J Clin Nutr (1982) 0.84
Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study. Am J Surg Pathol (1982) 0.84
Liver iron stores and hepatitis B antigen status. Cancer (1985) 0.83
Serum potassium changes following packed red cell transfusions in newborn infants. Transfusion (1983) 0.83
Adverse effects of postoperative infusion of shed mediastinal blood. Ann Thorac Surg (1996) 0.82
A red cell membrane protein abnormality in hereditary elliptocytosis. Br J Haematol (1973) 0.82
Bovine ferritin iron bioavailability in man. Eur J Clin Invest (1997) 0.82
Erythrocyte catabolism in the inflammatory peritoneal monocyte. Br J Haematol (1978) 0.82
Accuracy and precision in measurement of human serum immunoglobulins G, A and M. S Afr J Med Sci (1973) 0.82
Serum immunoglobulins G, A and M in White and Black adults on the Witwatersrand. S Afr Med J (1975) 0.82
Comparison of specific protein assays in biological fluids by radial immunodiffusion and laser nephelometer. Clin Biochem (1979) 0.82
Osteoporosis in Johannesburg Bantu males. Its relationship to siderosis and ascorbic acid deficiency. Am J Clin Nutr (1967) 0.81
Effect of fiber on nonheme iron absorption. Gastroenterology (1983) 0.81
Iron absorption in humans as influenced by bovine milk proteins. Am J Clin Nutr (1989) 0.81
Induction of tolerance to factor VIII in a child with a high-titer inhibitor: in vitro and in vivo observations. J Pediatr (1984) 0.81
Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency. S Afr Med J (1976) 0.81
Coagulation studies in long-term survivors after renal allograft transplantation. S Afr Med J (1976) 0.81
Hemophilia morbidity, cognitive functioning, and academic achievement. J Pediatr (1998) 0.81
Iron fortification of infant cereals: a proposal for the use of ferrous fumarate or ferrous succinate. Am J Clin Nutr (1989) 0.81
A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients. J Burn Care Rehabil (2001) 0.80
Progesterone administration induced impairment of insulin suppression of hepatic glucose production. Fertil Steril (1994) 0.80
Circadian variation in plasma iron concentration and reticuloendothelial iron release in the rat. Clin Sci Mol Med (1973) 0.80
Haemophilia-related morbidity and quality-of-life. Haemophilia (2005) 0.79
Frequency and causes of hospitalization in HIV-negative children and adolescents with haemophilia A or B and its effect on academic achievement. Haemophilia (2004) 0.79
Immunohistochemical ferritin in hepatocellular carcinoma. Cancer (1984) 0.79
Pure red cell aplasia. S Afr Med J (1976) 0.79
von Willebrand factor: what is its role in the immune response in haemophilia? Haemophilia (2011) 0.79
Immunohistochemical ferritin in testicular seminoma. Cancer (1984) 0.79
Canthaxanthin. Int J Dermatol (1985) 0.79
Multiple myeloma. II. The value of melphalan. S Afr Med J (1974) 0.79
Comparative effects of monomethylsuccinate and glucose on insulin secretion from perifused rat islets. Diabetes (1993) 0.79
Activity of intraperitoneal heparin during peritoneal dialysis. Clin Nephrol (1978) 0.79
Age and human immunodeficiency virus infection in persons with hemophilia in California. Am J Public Health (1990) 0.78
Hepatocellular enzyme patterns and hepatitis B virus exposure in multitransfused young and very young hemophilia patients. Am J Hematol (1981) 0.78
Biochemical determinants of iron absorption. Prog Clin Biol Res (1981) 0.78
Multiple myeloma. I. Clinical, biochemical and immunochemical aspects. S Afr Med J (1974) 0.78
Growth failure in boys with hemophilia and HIV infection. Am J Pediatr Hematol Oncol (1989) 0.78
Soy protein products and heme iron absorption in humans. Am J Clin Nutr (1985) 0.78